From $20 to $25: The Logic Behind My PFE LEAP Roll

On February 3, with Pfizer (PFE) trading at $25.50, I opened my original LEAP position.

Why I Entered

I originally opened this trade based on:

  • ๐Ÿ“Š An earnings beat and the stock tanked the same day due to profit taking
  • ๐Ÿ“‰ Consensus that the stock had been beaten down
  • ๐Ÿ“ˆ Analyst price targets ranging from $23โ€“$35 per share

This wasnโ€™t a lottery ticket.

It was a value-based thesis with defined risk.

My expectation was not explosive upside โ€” but stabilization and recovery within a range.


๐Ÿ“ February 3 โ€” Original Position

5 ร— Jun 17, 2027 $20 Calls

MetricValue
Underlying Price$25.50
Strike$20
Option Price$7.47
Delta~.90
Synthetic Shares450
Capital at Risk$3,735

๐Ÿงฎ Exposure Math

.90 ร— 100 ร— 5 = 450 synthetic shares

Capital committed:

$7.47 ร— 100 ร— 5 = $3,735

At .90 delta, I was essentially long 450 shares.

If PFE went to $0, I could lose $3,735.

That was my maximum defined risk.


๐Ÿง  How the Thesis Evolved

Even with analyst targets between $23 and $35, I donโ€™t expect a straight-line move.

My updated working assumptions:

  • ๐Ÿ“ฆ PFE likely channels
  • ๐Ÿ“‰ Worst-case realistic scenario around $14
  • ๐Ÿ’ฐ Premium harvesting matters more than max delta

Thatโ€™s what led to the roll.


๐Ÿ” The Roll to $25

I executed:

  • Sold 5 $20 Calls @ $7.47
  • Bought 5 $25 Calls @ $3.95

๐Ÿ’ฐ Roll Credit

$7.47 โ€“ $3.95 = $3.52 per contract

$3.52 ร— 100 ร— 5 = $1,760 credit received

Immediate capital reduction.


๐Ÿ“ New Position

5 ร— Jun 17, 2027 $25 Calls

MetricValue
Strike$25
Option Cost$3.95
Gross Capital at Risk$1,975

๐Ÿงฎ New Gross Risk

$3.95 ร— 100 ร— 5 = $1,975

That is the maximum loss on the LEAP itself.


๐Ÿ’ฐ Covered Call Income

I also collected:

$150 from selling covered calls.


๐Ÿ“Š True Net Capital at Risk

LEAP cost: $1,975
Minus covered call income: $150

= $1,825 net capital exposure

That is my real-world maximum downside today.


๐Ÿ“‰ Worst-Case Scenarios

If PFE Drops to $20

  • $25 calls go OTM
  • Delta shrinks
  • I still have time (2027 expiration)
  • I can continue selling calls

No forced assignment. No surprise purchase.


If PFE Drops to $14 (My Assumed Worst Case)

At expiration:

Calls expire worthless.

Loss = $1,825


If PFE Goes to $0

Same outcome.

Loss = $1,825

Defined risk remains defined.


โš–๏ธ Before vs After

February 3 PositionAfter Roll + Income
Strike$20$25
Delta.90Lower
Synthetic Shares450Reduced
Max Loss$3,735$1,825
Capital Freedโ€”$1,760

๐Ÿ“‰ Risk Reduction

$3,735 โ€“ $1,825 = $1,910 less maximum exposure

Thatโ€™s structural compression of risk.


๐ŸŽฏ Why This Still Fits the Original Thesis

Analysts see $23โ€“$35.

That supports upside potential.

But I structured the trade assuming:

  • It may stall near $23
  • It may grind toward $30
  • It may even dip before recovering

I donโ€™t need 450 synthetic shares for that.

I need:

  • Efficient exposure
  • Reduced capital risk
  • Flexibility to harvest premium

๐Ÿ“Œ Retail Trader Takeaway

If you remember nothing else from this post, remember this:

1๏ธโƒฃ Delta Is Exposure

A .90 delta LEAP is basically stock.

5 contracts ร— .90 delta = 450 synthetic shares

Ask yourself:

Do I really want that much directional exposure for this stock?


2๏ธโƒฃ Maximum Loss on a Long Call = Premium Paid (Minus Income)

Not the strike.
Not the intrinsic difference.
Not some scary theoretical number.

After the roll and covered call income:

True net max loss = $1,825

Even if PFE goes to $14.
Even if it goes to $0.

Defined risk means defined risk.


3๏ธโƒฃ Rolling for Credit Can Compress Risk

Before roll:

Max loss = $3,735

After roll + income:

Max loss = $1,825

Thatโ€™s $1,910 less exposure.

Rolling up didnโ€™t increase risk.

It materially reduced it.


4๏ธโƒฃ Structure Around Your Thesis

My thesis:

  • ๐Ÿ“ฆ Channeling stock
  • ๐Ÿข Slow movement
  • ๐Ÿ’ฐ Premium opportunities

If I believed PFE was about to rip higher, I would have kept the $20 strike and the .90 delta.

Position management should match probability โ€” not hope.


๐Ÿง  Final Thought

Trading LEAPS isnโ€™t about being right.

Itโ€™s about:

  • Managing exposure
  • Controlling maximum loss
  • Improving return on capital
  • Surviving the downside

This roll wasnโ€™t exciting.

It was disciplined.

And disciplined trading compounds.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *